» Articles » PMID: 16028440

Gastric Cancer Confined to the Muscularis Propria: a Possible Candidate for Laparoscopic Surgery or Adjuvant Therapy

Overview
Publisher Informa Healthcare
Specialty Gastroenterology
Date 2005 Jul 21
PMID 16028440
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Gastric cancer confined to the muscularis propria (mp) has a favorable prognosis, but still belongs to the advanced category. Many oncologists have difficulties in selecting treatment modalities owing to the confused situation of mp cancer. To clarify the therapeutic strategy, the clinicopathological characteristics were investigated, and the risk factors, of this intermediate-stage gastric cancer, evaluated.

Material And Methods: A total of 155 patients who underwent curative resection for primary gastric cancer between 1993 and 2001 were diagnosed with mp cancer. The patients were divided into recurrent and non-recurrent groups and analyzed clinicopathologically.

Results: The rate of recurrence was 20%. A multivariate analysis disclosed only lymphatic metastasis as an independent risk factor for recurrence of mp cancer. Hematogenous metastasis accounted for 37% of the recurrent patterns, and the liver (83.3%) was the most common organ. The 5-year survival rate of all mp cancer patients was 80.9%, but that of patients with recurrent disease was 19.2%. The median survival time of the recurred patients was 24 months, and 74% of those patients died within 3 years.

Conclusions: Lymph node metastasis is the only significant risk factor of mp cancer. Patients with lymphatic metastasis should undergo postoperative adjuvant therapy. On the other hand, patients with mp cancer without lymph node involvement have an excellent prognosis and could be candidates for laparoscopic gastric surgery.

Citing Articles

Evaluating the Role of Robotic Surgery Gastric Cancer Treatment: A Comprehensive Review by the Robotic Global Surgical Society (TROGSS) and European Federation International Society for Digestive Surgery (EFISDS) Joint Working Group.

Marano L, Cwalinski T, Girnyi S, Skokowski J, Goyal A, Malerba S Curr Oncol. 2025; 32(2).

PMID: 39996883 PMC: 11854667. DOI: 10.3390/curroncol32020083.


The Role of Minimally Invasive Surgery in Gastric Cancer.

Omarov N, Uymaz D, Azamat I, Ozoran E, Ozata I, Biricik F Cureus. 2021; 13(11):e19563.

PMID: 34796082 PMC: 8590860. DOI: 10.7759/cureus.19563.


Clinical Implication of Tumor-invasive Status into the Muscularis Propria in T2 Gastric Cancer.

Nakamura K, Ogimi M, Tomioku M, Hara H, Nabeshima K, Nomura E In Vivo. 2019; 33(4):1341-1346.

PMID: 31280228 PMC: 6689362. DOI: 10.21873/invivo.11609.


Robotic total gastrectomy with π-shaped esophagojejunostomy using a linear stapler as a novel technique.

Zhang S, Khaliq J, Li D, Jiang X, Sun R, Li Y World J Surg Oncol. 2018; 16(1):238.

PMID: 30577805 PMC: 6303991. DOI: 10.1186/s12957-018-1542-z.


Robotic gastrectomy for gastric cancer: Current evidence.

Alhossaini R, Altamran A, Seo W, Hyung W Ann Gastroenterol Surg. 2018; 1(2):82-89.

PMID: 29863139 PMC: 5881341. DOI: 10.1002/ags3.12020.